1. Home
  2. MAZE vs FPI Comparison

MAZE vs FPI Comparison

Compare MAZE & FPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAZE
  • FPI
  • Stock Information
  • Founded
  • MAZE 2018
  • FPI 2013
  • Country
  • MAZE United States
  • FPI United States
  • Employees
  • MAZE N/A
  • FPI N/A
  • Industry
  • MAZE
  • FPI Real Estate Investment Trusts
  • Sector
  • MAZE
  • FPI Real Estate
  • Exchange
  • MAZE NYSE
  • FPI Nasdaq
  • Market Cap
  • MAZE 523.1M
  • FPI 607.9M
  • IPO Year
  • MAZE 2025
  • FPI 2014
  • Fundamental
  • Price
  • MAZE $11.01
  • FPI $11.15
  • Analyst Decision
  • MAZE Strong Buy
  • FPI
  • Analyst Count
  • MAZE 3
  • FPI 0
  • Target Price
  • MAZE $25.67
  • FPI N/A
  • AVG Volume (30 Days)
  • MAZE 266.1K
  • FPI 392.0K
  • Earning Date
  • MAZE 01-01-0001
  • FPI 04-29-2025
  • Dividend Yield
  • MAZE N/A
  • FPI 2.14%
  • EPS Growth
  • MAZE N/A
  • FPI 101.08
  • EPS
  • MAZE 1.25
  • FPI 1.06
  • Revenue
  • MAZE $167,500,000.00
  • FPI $58,351,000.00
  • Revenue This Year
  • MAZE N/A
  • FPI N/A
  • Revenue Next Year
  • MAZE N/A
  • FPI $2.82
  • P/E Ratio
  • MAZE $8.81
  • FPI $10.55
  • Revenue Growth
  • MAZE N/A
  • FPI 1.54
  • 52 Week Low
  • MAZE $9.88
  • FPI $9.70
  • 52 Week High
  • MAZE $17.00
  • FPI $12.87
  • Technical
  • Relative Strength Index (RSI)
  • MAZE N/A
  • FPI 46.85
  • Support Level
  • MAZE N/A
  • FPI $10.94
  • Resistance Level
  • MAZE N/A
  • FPI $11.19
  • Average True Range (ATR)
  • MAZE 0.00
  • FPI 0.19
  • MACD
  • MAZE 0.00
  • FPI 0.04
  • Stochastic Oscillator
  • MAZE 0.00
  • FPI 87.50

About MAZE MAZE THERAPEUTICS INC

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, citrus, blueberries, and vegetables. The company generates its revenues through the rent it receives from its tenants.

Share on Social Networks: